Overview

Absorption of Indacaterol and Glycopyrronium From Ultibro Breezhaler

Status:
Completed
Trial end date:
2021-09-21
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess pharmacokinetics (PK) of indacaterol and glycopyrronium, and methodology and practical arrangements for future studies.
Phase:
Phase 1
Details
Lead Sponsor:
Orion Corporation, Orion Pharma
Treatments:
Bromides
Charcoal
Glycopyrrolate
Maleic acid